AIFF (Firefly Neuroscience) ROCE %: -99.14% (As of Mar. 2026)


AIFF Firefly Neuroscience Inc AIFF
9 GF Score
Price $1.32
! 4 Warning Signs
View Full Analysis

What is Firefly Neuroscience ROCE %?

Firefly Neuroscience AIFF +4.37% 9 ROCE % is -99.14% as of Mar. 2026. GuruFocus rates AIFF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Firefly Neuroscience's annualized ROCE % for the quarter that ended in Mar. 2026 was -99.14%.

Firefly Neuroscience  (NAS:AIFF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Firefly Neuroscience ROCE % Related Terms

Firefly Neuroscience ROCE % Historical Data

* Premium members only.

The historical data trend for Firefly Neuroscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Firefly Neuroscience ROCE % Chart

Firefly Neuroscience Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
0.00 0.00 0.00 0.00 -541.48

Firefly Neuroscience Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,129.23 -83.75 -96.34 -114.06 -99.14
AIFF
9GF Score
Firefly Neuroscience Inc AIFF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Firefly Neuroscience ROCE % Calculation

Firefly Neuroscience's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-19.718/( ( (4.601 - 4.976) + (10.477 - 2.819) )/ 2 )
=-19.718/( (-0.375+7.658)/ 2 )
=-19.718/3.6415
=-541.48 %

Firefly Neuroscience's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-7.988/( ( (10.477 - 2.819) + (10.91 - 2.454) )/ 2 )
=-7.988/( ( 7.658 + 8.456 )/ 2 )
=-7.988/8.057
=-99.14 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -99.14% mean?
Firefly Neuroscience (AIFF) has a ROCE % of -99.14% as of Mar. 2026.
Is Firefly Neuroscience's ROCE % too high?
Firefly Neuroscience's current ROCE % is -99.14%. Overall, Firefly Neuroscience has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's ROCE % compare to LPSN and AVAI?
Firefly Neuroscience's ROCE % of -99.14% can be compared against companies in the Software industry. The industry median ROCE % is 5.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Software company?
The median ROCE % among Software companies is 5.27, based on 2,713 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median ROCE % is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Firefly Neuroscience's current ROCE % is -99.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current ROCE % of -99.14%. The current ROCE % is -99.14%. Firefly Neuroscience's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current ROCE % is -99.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Firefly Neuroscience Business Description

Address 1100 Military Road, Kenmore, NY, USA, 14217
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
9GF Score

Get the complete analysis for AIFF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.32
Price